Investors

Overview

Corporate Profile

Gamida Cell is an advanced cell therapy company committed to finding cures for patients with cancer and other serious diseases. We harness our NAM-enabled technology platform to create therapies with the potential to improve the course of cancer care.

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Latest News

View All
Nov 16, 2021

Gamida Cell to Present Corporate Highlights at Multiple Upcoming Investor Conferences

Read More
Nov 15, 2021

Gamida Cell Reports Third Quarter 2021 Financial Results and Provides Company Update

Read More
Nov 11, 2021

Gamida Cell Provides Update on Pre-BLA Meeting With FDA for Omidubicel

Read More
Nov 09, 2021

Gamida Cell Presents New Data on Nicotinamide-Enabled NK Cell Therapy at Society for Immunotherapy of Cancer's (SITC) 36th Annual Meeting

Read More
Nov 08, 2021

Gamida Cell Announces the Date of Its Third Quarter 2021 Financial Results and Webcast

Read More
Nov 04, 2021

Gamida Cell Announces Data to Be Presented at 63rd ASH Annual Meeting

Read More
Nov 04, 2021

Gamida Cell Presents Data on its NAM-Enabled NK Cell Therapies at Protein & Antibody Engineering Summit (PEGS) Europe

Read More
Oct 26, 2021

Gamida Cell to Present NAM-Enabled, Genetically Modified NK Cell Therapy Pipeline and Update on GDA-201 at Today’s Virtual R&D Day

Read More
Oct 19, 2021

Gamida Cell to Present at Society for Immunotherapy of Cancer's (SITC) 36th Annual Meeting

Read More
Sep 28, 2021

Gamida Cell to Host Virtual Event Highlighting GDA-201 and NAM-Enabled, Genetically Modified NK Cell Therapy Pipeline

Read More
Sep 02, 2021

Gamida Cell to Present Corporate Highlights at Multiple Investor Conferences in September

Read More
Aug 11, 2021

Gamida Cell Reports Second Quarter 2021 Financial Results and Provides Company Update

Read More
Aug 04, 2021

Gamida Cell Announces the Date of Its Second Quarter 2021 Financial Results and Webcast

Read More
Aug 03, 2021

Gamida Cell to Present at the BTIG Virtual Biotechnology Conference

Read More
Jun 23, 2021

Gamida Cell Announces Publication in Blood, the Journal of the American Society of Hematology, of the First Pivotal Trial to Evaluate a Cell Therapy (Omidubicel) for Patients with Blood Cancer who Require an Allogeneic Stem Cell Transplant

Read More
Jun 09, 2021

Gamida Cell to Present Corporate Highlights at Multiple Investor Conferences in June

Read More
Jun 07, 2021

Gamida Cell Announces Appointment of Senior Vice President, Global Operations and Manufacturing and Provides Commercial Manufacturing Update

Read More
May 12, 2021

Gamida Cell to Present at the RBC Capital Markets Global Healthcare Conference

Read More
May 11, 2021

Gamida Cell Reports First Quarter 2021 Financial Results and Provides Company Update

Read More
May 04, 2021

Gamida Cell Announces the Date of Its First Quarter 2021 Financial Results and Webcast

Read More